 BILLERICA, Mass.--BUSINESS WIRE--Quanterix Corporation NASDAQ: QTRX, a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Drug Administration FDA has issued an Emergency Use Authorization EUA for its Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test that can be run on the Simoa HD-X Analyzer, a fully automated high-throughput immunoassay instrument. The Simoa Semi-Quantitative SARS-CoV-2 antibody test targets antibodi 